Cell Cryopreservation Market Outlook:
Cell Cryopreservation Market size was valued at USD 14.32 billion in 2025 and is projected to reach USD 101.98 billion by 2036, growing at a CAGR of 18.91% during the forecast period (2026-2036). In 2026, the industry size of cell cryopreservation is expected to be USD 18.05 billion.
Growing demand from the healthcare sector and the shift toward personalized medicine are significantly fuelling the cell cryopreservation market, as more cell-based therapies are tailored to individual patients. The NIH’s All of Us Research Program, for example, has exceeded 633,000 participants in its precision-medicine biobank, providing rich biospecimen data that must be properly cryopreserved. Simultaneously, there are over 1,744 CAR-based (cell/gene) therapy trials registered on ClinicalTrials.gov, showing how the clinical pipeline is increasingly patient-specific. This personalized-treatment trend requires large-scale, validated cryobanking, controlled-rate freezing, and cold-chain logistics to maintain cell viability, driving growth in cryopreservation infrastructure.
Strong government support for stem cell research and preservation is further driving the growth of the cell cryopreservation market. Moreover, artificial intelligence (AI) is playing an increasingly important role in advancing cell cryopreservation by improving efficiency, precision, and reproducibility across key processes. AI algorithms can analyze large datasets to determine the optimal freezing and thawing conditions, such as cooling rates, cryoprotectant concentrations, and storage temperatures, to maximize cell viability and functionality.
